Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Mnif MF, Kamoun M, Mnif F, Charfi N, Naceur BB, Kallel N, Rekik N, Mnif Z, Sfar MH, Sfar MT, Hachicha M, Abid M.

Indian J Endocrinol Metab. 2012 Nov;16(6):939-46. doi: 10.4103/2230-8210.102995.

PMID:
23226639
[PubMed]
Free PMC Article
2.

Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Kim MS, Merke DP.

Semin Reprod Med. 2009 Jul;27(4):316-21. doi: 10.1055/s-0029-1225259. Epub 2009 Jun 15. Review.

PMID:
19530065
[PubMed - indexed for MEDLINE]
3.

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.

Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.

Endokrynol Pol. 2010 Jan-Feb;61(1):142-55. Review.

PMID:
20205117
[PubMed - indexed for MEDLINE]
Free Article
4.

Classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in adults.

Bachelot A, Chakthoura Z, Rouxel A, Dulon J, Touraine P.

Horm Res. 2008;69(4):203-11. doi: 10.1159/000113020. Epub 2008 Jan 21. Review.

PMID:
18204267
[PubMed - indexed for MEDLINE]
5.

Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Bachelot A, Chakhtoura Z, Rouxel A, Dulon J, Touraine P.

Ann Endocrinol (Paris). 2007 Sep;68(4):274-80. Epub 2007 Aug 8. Review.

PMID:
17689481
[PubMed - indexed for MEDLINE]
6.

[Congenital adrenal hyperplasia].

Stanić M, Nesović M.

Med Pregl. 1999 Nov-Dec;52(11-12):447-54. Review. Croatian.

PMID:
10748766
[PubMed - indexed for MEDLINE]
7.

Classic congenital adrenal hyperplasia and puberty.

Charmandari E, Brook CG, Hindmarsh PC.

Eur J Endocrinol. 2004 Nov;151 Suppl 3:U77-82. Review.

PMID:
15554890
[PubMed - indexed for MEDLINE]
Free Article
8.

[Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].

Völler H, Schmailzl KJ, Bjarnason-Wehrens B.

Z Kardiol. 2004 Jul;93(7):503-13. Review. German.

PMID:
15243761
[PubMed - indexed for MEDLINE]
9.

Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Dörr HG.

Horm Res. 2007;68 Suppl 5:93-9. doi: 10.1159/000110587. Epub 2007 Dec 10. Review.

PMID:
18174719
[PubMed - indexed for MEDLINE]
10.

Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.

Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI.

J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):19-29. Review.

PMID:
10418977
[PubMed - indexed for MEDLINE]
11.

Factors determining final height in congenital adrenal hyperplasia.

New MI; International Workshop on Management of Puberty for Optimum Auxological Results.

J Pediatr Endocrinol Metab. 2001 Jul;14 Suppl 2:933-7. Review.

PMID:
11529398
[PubMed - indexed for MEDLINE]
12.

Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.

Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H; MEWPE-CAH Study Group.

Horm Res. 2001;55(4):161-71. Review.

PMID:
11598369
[PubMed - indexed for MEDLINE]
13.

Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.

Manco M.

J Am Coll Nutr. 2011 Oct;30(5):295-303. Review.

PMID:
22081615
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk